Mercado cerrado -
Otros sitios de cotización
|
Después de cerrar 21:59:58 | |||
91,18 EUR | +1,79 % | 90,98 | -0,22 % |
16:08 | Marble Bar Asset Management recorta posiciones cortas en OVS | AN |
18/04 | Marshall Wace se mueve en Leonardo y OVS | AN |
Resumen de negocios
A finales de 2023, el grupo contaba con 10 centros de producción situados en Italia, Estados Unidos (6), Canadá, Alemania y Reino Unido.
Número de empleados: 3 209
Ventas por actividad
EUR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Diagnostic Kits
100,0
%
| 1 361 | 100,0 % | 1 148 | 100,0 % | -15,64 % |
Ventas por región
EUR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
North America
52,9
%
| 783 | 57,5 % | 607 | 52,9 % | -22,41 % |
Europe
23,1
%
| 269 | 19,8 % | 265 | 23,1 % | -1,53 % |
Italy
15,1
%
| 198 | 14,5 % | 174 | 15,1 % | -12,14 % |
Rest of the World
8,9
%
| 112 | 8,2 % | 102 | 8,9 % | -8,48 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Carlo Rosa
CEO | Chief Executive Officer | 58 | 01/01/98 |
Director of Finance/CFO | 53 | 01/01/11 | |
Director/Board Member | 61 | 01/01/00 | |
Riccardo Fava
IRC | Investor Relations Contact | - | - |
Stefano Ronchi
HRO | Human Resources Officer | 64 | 01/01/07 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 65 | 29/04/22 | |
Carlo Rosa
CEO | Chief Executive Officer | 58 | 01/01/98 |
Director/Board Member | 61 | 01/01/00 | |
Franco Moscetti
BRD | Director/Board Member | 72 | 26/03/07 |
Diego Pistone
BRD | Director/Board Member | 73 | 29/04/22 |
Luca Melindo
BRD | Director/Board Member | 53 | 24/04/19 |
Monica Tardivo
BRD | Director/Board Member | 54 | 28/04/16 |
Roberta Somati
BRD | Director/Board Member | 55 | 22/04/13 |
Stefano Altara
BRD | Director/Board Member | 56 | 23/04/14 |
Director/Board Member | 64 | 28/04/16 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 55 948 257 | 21 096 501 ( 37,71 %) | 2 588 278 ( 4,626 %) | 37,71 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
DIASORIN S.P.A. 4.86% | 2 716 663 | 4.86% | 262 592 646 $ |
IMPEDIMED LIMITED 0.66% | 13 300 000 | 0.66% | 798 266 $ |
Información de la empresa
Empresas del grupo
Nombre | Categoría y sector |
---|---|
Luminex Molecular Diagnostics, Inc.
Luminex Molecular Diagnostics, Inc. Medical/Nursing ServicesHealth Services Luminex Molecular Diagnostics, Inc. develops DNA based diagnostics tests and software solutions, which include genetic tests for disorders, drug metabolism and infectious diseases. The firm’s products include P450-2D6, P450-2C9, P450-2C19, AJ panel and CFTR. The company was founded in March 2007 and is headquartered in Toronto, Canada. |
Medical/Nursing Services
|
Diasorin, Inc.
Diasorin, Inc. Medical SpecialtiesHealth Technology Diasorin, Inc. develops and manufactures reagents for in vitro diagnostics. It has products in the fields of infectious disease, hepatitis, endocrinology, bone and mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The company was founded in 1975 and is headquartered in Stillwater, MN. |
Medical Specialties
|
Diasorin Italia SpA
Diasorin Italia SpA Medical/Nursing ServicesHealth Services Part of DiaSorin SpA, Diasorin Italia SpA is a diagnostic specialist that develops, produces, and globally markets reagent kits for in vitro diagnostics. Diasorin Italia is based in Saluggia, Italy. The Italian company continues to invest in research and development, leveraging its expertise in immunodiagnostics to deliver high-quality assays and improve laboratory efficiency. Ugo Gay has been the CEO of the private company since 2000. |
Medical/Nursing Services
|
Sector
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-2,21 % | 5097,47 M | |
-1,04 % | 12,47 mil M | |
-17,29 % | 6992,71 M | |
+2,92 % | 4272,81 M | |
-4,79 % | 4270,25 M | |
-50,07 % | 3449,87 M | |
+7,65 % | 2610,36 M | |
-15,92 % | 2082,16 M | |
-3,34 % | 1674,75 M | |
-13,66 % | 1480,92 M |
- Bolsa de valores
- Acciones
- Acción DIA
- Empresa DiaSorin S.p.A.